SCHEMBL5936638

SCHEMBL5936638

O=C(Nc1cc[c]cc1)c1cccc(OCc2cccc(OCc3ccccc3)c2)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 5/20 0.69
KMT2A Q03164 6/20 0.66
MEN1 O00255 5/20 0.66
SMPD1 P17405 1/20 0.63
NPC1 O15118 2/20 0.61
RAB9A P51151 2/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
MAPT P10636 5/20 0.60
USP2 O75604 1/20 0.60
MAPK1 P28482 1/20 0.60
ESR2 Q92731 1/20 0.60
TAAR1 Q96RJ0 1/20 0.60
GUSB P08236 1/20 0.60
NR4A2 P43354 1/20 0.58
LMNA P02545 2/20 0.58
HPGD P15428 1/20 0.58
HTT P42858 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
KDM4E B2RXH2 1/20 0.58
ALDH1A1 P00352 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5936675 0.94 NR1H4 (0.67) NR1H4KMT2AMEN1SMPD1NPC1
SCHEMBL27966079 0.85 NR1H4 (0.71) NR1H4KMT2AMEN1SMPD1NPC1
SCHEMBL7078440 0.83 NR1H4 (0.72) NR1H4KMT2AMEN1SMPD1NPC1
SCHEMBL5936634 0.82 SMPD1 (0.62) NR1H4KMT2AMEN1SMPD1RAB9A
SCHEMBL9415806 0.81 NR1H4 (1.00) NR1H4KMT2AMEN1SMPD1NPC1
SCHEMBL11550139 0.81 NR1H4 (0.81) NR1H4KMT2AMEN1SMPD1NPC1
SCHEMBL7076430 0.81 KMT2A (0.65) NR1H4KMT2AMEN1SMPD1NPC1
SCHEMBL15838871 0.78 SMPD1 (0.77) NR1H4KMT2AMEN1SMPD1NPC1
SCHEMBL7410475 0.78 SMPD1 (0.78) NR1H4KMT2AMEN1SMPD1NPC1
SCHEMBL1608032 0.78 SMPD1 (1.00) NR1H4KMT2AMEN1SMPD1GUSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160894-A1 Benzamides as ppar modulators LABORATORIOS S.A.L.V.A.T.,S.A. (ES) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160894-A1 Benzamides as ppar modulators PPARD, PPARA, PPARG NR1H4 160/4885KMT2A 1515/4885MEN1 4877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.